Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Oncology | Pathology | Journal

Back to Journal Articles

Hedgehog Pathway Key in Tamoxifen-Resistant Breast CA

Last Updated: November 06, 2012.

 

Elements of Hh signaling pathway protected from proteasomal degradation by PI3K/AKT pathway

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Noncanonical Hedgehog signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B pathway plays a key role protecting Hedgehog signaling molecules, according to a study published in the Oct. 1 issue of Cancer Research.

TUESDAY, Nov. 6 (HealthDay News) -- Noncanonical Hedgehog (Hh) signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B (PI3K/AKT) pathway plays a key role protecting Hh signaling molecules, according to a study published in the Oct. 1 issue of Cancer Research.

Noting that patients with resistance to endocrine therapy have poor outcomes, Bhuvaneswari Ramaswamy, M.D., from The Ohio State University in Columbus, and colleagues examined the role of Hh signaling in tamoxifen-resistant tumors.

The researchers found that the Hh signaling pathway was activated in tamoxifen-resistant tumors and that the PI3K/AKT pathway protected key components of the Hh signaling pathway from proteasomal degradation. In tamoxifen-resistant MCF-7 and T47D cells, the levels of Hh signaling molecules SMO and GLI1 and their targets were found to be significantly elevated. Serial passage of the resistant cells in mice led to aggressive tumors, which spread to distant organs, and simultaneous increases in Hh marker expression. SMO or GLI1 depletion mediated by RNAi correlated with reduced proliferation, clonogenic survival, and delayed transition from G1 to S. Treatment of resistant cells with PI3K inhibitors resulted in reduced SMO and GLI1 protein levels and activity, while blocking GSK3β and proteasomal degradation rescued these levels and activity. Anti-Hh compound GDC-0449 treatment of tamoxifen-resistant xenografts correlated with blocked tumor growth in mice. In a cohort of 315 patients with breast cancer, high GLI1 expression was inversely associated with disease-free and overall survival.

"In summary, our results describe a signaling event linking PI3K/AKT pathway with Hh signaling that promotes tamoxifen resistance," the authors write. "Targeting Hh pathway alone or in combination with PI3K/AKT pathway could therefore be a novel therapeutic option in treating endocrine-resistant breast cancer."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: AHA: Social Cocaine Use Tied to Environment for Heart Attack Next: Experimental Study Finds Sperm Stem Cells Can Reverse Infertility

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.